Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Azacitidine and Donor Lymphocyte Infusions As Treatment For Relapse After Allogeneic Stem Cell Transplantation - a Retrospective Multicenter Analysis In 115 Patients On Behalf Of The German Cooperative Transplant Study Group

Blood (2013) 122 (21): 4642.

https://doi.org/10.1182/blood.V122.21.4642.4642

Published: 2013

Journal Articles

Sociology of Normal Stem and Progenitor Cells in CML Niche

Robert S Welner, PhD, Giovanni Amabile, PhD, Deepak Bararia, PhD, Philipp B. Staber, M.D., Akos G. Czibere, MD, PhD, Daniel G Tenen, MD

Blood (2012) 120 (21): 1234.

https://doi.org/10.1182/blood.V120.21.1234.1234

Published: 2012

Journal Articles

Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation

Thomas Schroeder, MD, Julia Fröbel, Ron Patrick Cadeddu, Akos G. Czibere, MD, Ariane Dienst, Esther Zipperer, MD, Uwe Platzbecker, MD, Gesine Bug, Lutz Uharek, MD, Roland Fenk, MD, Ulrich Germing, Nicolaus Kröger, Rainer Haas, MD, Guido Kobbe, MD

Blood (2012) 120 (21): 1964.

https://doi.org/10.1182/blood.V120.21.1964.1964

Published: 2012

Journal Articles

TIMP–1 Plays a Functional Role in CD34. + Hematopoietic Stem and Progenitor Cells.

C. Matthias Wilk, Akos G. Czibere, MD, PhD, Ron-Patrick Cadeddu, Sebastian Buest, Frank A. Schildberg, Marcel A. Lauterbach, Volker Westphal, PhD, Stefan W. Hell, Prof., Rainer Haas, Prof., Ingmar Bruns, MD, PhD

Blood (2009) 114 (22): 1487.

https://doi.org/10.1182/blood.V114.22.1487.1487

Published: 2009

Journal Articles

Malignant Myeloma Cells Impair Phenotype and Function of stem and Progenitor Cells.

Ingmar Bruns, MD, PhD, Sebastian Büst, Akos G. Czibere, MD, Ron-Patrick Cadeddu, Ines Brückmann, Manoj Bhasin, Johannes C Fischer, Roland Fenk, Guido Kobbe, MD, Andreas Trumpp, Rainer Haas

Blood (2009) 114 (22): 1799.

https://doi.org/10.1182/blood.V114.22.1799.1799

Published: 2009

Journal Articles

Clinical Efficacy of Sorafenib in Patients with Acute Myeloid Leukemia (AML) and Activating FLT3-Mutations.

Thomas Schroeder, MD, Christian Saure, Ingmar Bruns, MD, PhD, Fabian Zohren, Akos G. Czibere, MD, Nelly Nancy Safaian, Roland Fenk, Rainer Haas, Guido Kobbe, MD

Blood (2009) 114 (22): 2057.

https://doi.org/10.1182/blood.V114.22.2057.2057

Published: 2009

Journal Articles

Quantitative Real-Time PCR of Peripheral Blood t(14;18) Positive Cells Predicts Treatment Response and Long-Term Outcome in Patients with Follicular Lymphoma.

Fabian Zohren, Ingmar Bruns, MD, PhD, Juergen Barth, Sabrina Pechtel, Roland Fenk, Thomas Schroeder, Akos G. Czibere, MD, Georg Maschmeyer, Dorothea Kofahl-Krause, Gerhard Heil, Norbert Niederle, Christoph Losem, Manfred Welslau, Ulrich Germing, Ralf Kronenwett, Rainer Haas, Mathias J Rummel, MD, PhD, Guido Kobbe, MD

Blood (2009) 114 (22): 441.

https://doi.org/10.1182/blood.V114.22.441.441

Published: 2009

Journal Articles

Neuropeptides Orexin A and B Are Funktionally Aktive in CD34+ Hematopoietic Stem and Progenitor Cells.

Ron-Patrick Cadeddu, Akos G. Czibere, MD, Sebastian Büst, Johannes C Fischer, Ulrich Steidl, MD, PhD, Ralf Kronenwett, Guido Kobbe, MD, Rainer Haas, Ingmar Bruns, MD, PhD

Blood (2009) 114 (22): 4593.

https://doi.org/10.1182/blood.V114.22.4593.4593

Published: 2009

Journal Articles

A Quality of Life Study Utilizing the EORTC QLQ-30 and EORTC QLQ-HDC29 Questionnaires for the Interview of 215 Patients Who Received Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Akos G. Czibere, MD, Verena Heymann, Ingmar Bruns, MD, PhD, Thomas Schroeder, Roland Fenk, Fabian Zohren, Mustafa Kondakci, Sebastian Balleisen, Rainer Haas, Guido Kobbe, MD

Blood (2009) 114 (22): 2470.

https://doi.org/10.1182/blood.V114.22.2470.2470

Published: 2009

Journal Articles

Platelets Derived From Patients with Myelodysplastic Syndromes (MDS) Show Defective Platelet Aggregation and Integrin aIIbβ3 Receptor (GPIIb/IIIa) Signaling Caused by a Reduced Expression of Proteins Required for Inside-out Signaling.

Akos G. Czibere, MD, Julia Fröbel, Sonja Hartwig, Ron-Patrick Cadeddu, Matthias Wilk, Ingmar Bruns, MD, PhD, Sebastian Büst, Guido Kobbe, MD, Andrea Kündgen, Jürgen Eckel, Stefan Lehr, Rainer Haas

Blood (2009) 114 (22): 598.

https://doi.org/10.1182/blood.V114.22.598.598

Published: 2009

Journal Articles

Relevance of HLA-C Epitopes C1 and C2 for the Survival of Patients with AML and CML after Allogeneic Blood Stem Cell Transplantation.

Ingmar Bruns, MD, Akos G. Czibere, MD, Markus Uhrberg, Jürgen Enczmann, MD, Guido Kobbe, MD, Frank Neumann, MD, Peter Wernet, MD, Rainer Haas, MD, Johannes C. Fischer, MD

Blood (2007) 110 (11): 1974.

https://doi.org/10.1182/blood.V110.11.1974.1974

Published: 2007

Journal Articles

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Ingmar Bruns, MD, Johannes C. Fischer, MD, Akos G. Czibere, MD, Cangül Kilic, Roland Fenk, MD, Fabian Zohren, MD, Ralf Kronenwett, MD, Rainer Haas, MD, Ralf Kronenwett, MD

Blood (2007) 110 (11): 4920.

https://doi.org/10.1182/blood.V110.11.4920.4920

Published: 2007

Journal Articles

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Ingmar Bruns, MD, Akos G. Czibere, MD, Johannes C. Fischer, MD, Ulrich Steidl, MD, PhD, Sabrina Pechtel, Annemarie Koch, Daniela Brünnert, Sebastian Büst, Ron-Patrick Cadeddu, Ralf Kronenwett, MD, Rainer Haas, MD

Blood (2007) 110 (11): 3170.

https://doi.org/10.1182/blood.V110.11.3170.3170

Published: 2007

NARROW

Azacitidine and Donor Lymphocyte Infusions As Treatment For Relapse After Allogeneic Stem Cell Transplantation - a Retrospective Multicenter Analysis In 115 Patients On Behalf Of The German Cooperative Transplant Study Group

Sociology of Normal Stem and Progenitor Cells in CML Niche

Salvage Therapy with Azacitidine Increases Regulatory T Cells in Patients with AML or MDS and Early Relapse After Allogeneic Blood Stem Cell Transplantation

TIMP–1 Plays a Functional Role in CD34. + Hematopoietic Stem and Progenitor Cells.

Malignant Myeloma Cells Impair Phenotype and Function of stem and Progenitor Cells.

Clinical Efficacy of Sorafenib in Patients with Acute Myeloid Leukemia (AML) and Activating FLT3-Mutations.

Quantitative Real-Time PCR of Peripheral Blood t(14;18) Positive Cells Predicts Treatment Response and Long-Term Outcome in Patients with Follicular Lymphoma.

Neuropeptides Orexin A and B Are Funktionally Aktive in CD34+ Hematopoietic Stem and Progenitor Cells.

A Quality of Life Study Utilizing the EORTC QLQ-30 and EORTC QLQ-HDC29 Questionnaires for the Interview of 215 Patients Who Received Autologous or Allogeneic Hematopoietic Stem Cell Transplantation.

Platelets Derived From Patients with Myelodysplastic Syndromes (MDS) Show Defective Platelet Aggregation and Integrin aIIbβ3 Receptor (GPIIb/IIIa) Signaling Caused by a Reduced Expression of Proteins Required for Inside-out Signaling.

Relevance of HLA-C Epitopes C1 and C2 for the Survival of Patients with AML and CML after Allogeneic Blood Stem Cell Transplantation.

Patient Characteristics Associated with Successful Mobilization of Peripheral Blood Stem and Progenitor Cells Following Cytotoxic Chemotherapy and Peg-G-CSF Stimulation.

Molecular Signature of Distinct CD34+ Hematopoietic Stem and Progenitor Cell Subsets of Patients with CML in Chronic Phase.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only